SCHEMBL9745455

SCHEMBL9745455

NC(/C=C/CP)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9745461 1.00
SCHEMBL14030614 0.78
SCHEMBL8617997 0.78
SCHEMBL8618000 0.78
SCHEMBL17142340 0.76
SCHEMBL13227971 0.76
SCHEMBL26963225 0.76 CYP2D6 (0.50)
SCHEMBL21086885 0.76
SCHEMBL22996014 0.74 CTH (0.42)
SCHEMBL9468613 0.74 CTH (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5175344-A Anticonvulsants, anxiolytic agents CIBA-GEIGY CORPORATION (US) 1992-12-29 US disclosed
EP-0233154-B1 UNSATURATED AMINO-ACIDS CIBA-GEIGY AG (CH) 1991-12-18 EP disclosed
US-5051413-A For treatment of ischemia, antispasmodic agents, anticonvulsants and anxiety or manic conditions CIBA-GEIGY CORPORATION (US) 1991-09-24 US disclosed
EP-0302826-A2 Process for the preparation of unsaturated amino acid compounds CIBA-GEIGY AG (CH) 1989-02-08 EP disclosed
EP-0233154-A2 Unsaturated amino-acids CIBA-GEIGY AG (CH) 1987-08-19 EP disclosed